{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:16:50Z","timestamp":1789676210520,"version":"4.0.1"},"reference-count":83,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Detachment of cells from the extracellular matrix into the peritoneal cavity initiates a cascade of metabolic alterations, leading usually to cell death by apoptosis, so-called\n                    <jats:italic>anoikis<\/jats:italic>\n                    . Glycolytic enzymes enable the switch from oxidative phosphorylation to aerobic glycolysis and allow resistance to anoikis of shed tumour cells. These enzymes also have moonlighting activities as protein kinases and transcription factors. Phosphoglycerate kinase (PGK) and pyruvate kinase are the only glycolytic enzymes generating ATP in the hexokinase pathway. Hypoxia, EGFR activation, expression of K-Ras G12V and B-Raf V600E induce mitochondrial translocation of phosphoglycerate kinase 1 (PGK1). Mitochondrial PGK1 acts as a protein kinase to phosphorylate pyruvate dehydrogenase kinase 1 (PDHK1), reducing mitochondrial pyruvate utilization, suppressing reactive oxygen species production, increasing lactate production and promoting tumourigenesis. PGK1 also plays a role as a transcription factor once transported into the nucleus. Resistance to anoikis is also facilitated by metabolic support provided by cancer-associated fibroblasts (CAFs). Our series of experiments in-vitro and in the animal model showed that PGK1 knock-out or inhibition is effective in controlling development and growth of peritoneal metastasis (PM) of gastric origin, establishing a causal role of PGK1 in this development. PGK1 also increases CXCR4 and CXCL12 expression, which is associated with a metastatic phenotype and plays a role in the metastatic homing of malignant cells. Thus, PGK1, its modulators and target genes may be exploited as therapeutic targets for preventing development of PM and for enhancing cytotoxic effects of conventional systemic chemotherapy.\n                  <\/jats:p>","DOI":"10.1515\/pp-2019-0003","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T05:02:17Z","timestamp":1552453337000},"source":"Crossref","is-referenced-by-count":41,"title":["Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes"],"prefix":"10.1515","volume":"4","author":[{"given":"Robert B.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Surgery , University of South New Wales , Sydney , Australia"},{"name":"Department of Upper Gastrointestinal Surgery , Liverpool Hospital , Elizabeth St, Liverpool , Sydney , New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Solass","sequence":"additional","affiliation":[{"name":"Institute of Pathology , University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Archid","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery , University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank-J\u00fcrgen","family":"Weinreich","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery , University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery , University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Reymond","sequence":"additional","affiliation":[{"name":"Department of General and Transplant Surgery , University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"2025120909211363390_j_pp-2019-0003_ref_001_w2aab3b7b4b1b6b1ab1c14b1Aa","doi-asserted-by":"crossref","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Tykarski A, Ksi\u0105\u017cek K. The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci. 2018;75:509\u201325.2895606510.1007\/s00018-017-2663-1","DOI":"10.1007\/s00018-017-2663-1"},{"key":"2025120909211363390_j_pp-2019-0003_ref_002_w2aab3b7b4b1b6b1ab1c14b2Aa","doi-asserted-by":"crossref","unstructured":"Steinert R, Hantschick M, Vieth M, Gastinger I, K\u00fchnel F, Lippert H, et al. Influence of subclinical tumour spreading on survival after curative surgery for colorectal cancer. Arch Surg. 2008;143:122\u20138.10.1001\/archsurg.2007.4918283136","DOI":"10.1001\/archsurg.2007.49"},{"key":"2025120909211363390_j_pp-2019-0003_ref_003_w2aab3b7b4b1b6b1ab1c14b3Aa","doi-asserted-by":"crossref","unstructured":"Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Hoshi N, et al. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma. Pancreatology. 2017;17:109\u201314.10.1016\/j.pan.2016.11.00127840175","DOI":"10.1016\/j.pan.2016.11.001"},{"key":"2025120909211363390_j_pp-2019-0003_ref_004_w2aab3b7b4b1b6b1ab1c14b4Aa","doi-asserted-by":"crossref","unstructured":"Higaki E, Yanagi S, Gotohda N, Kinoshita T, Kuwata T, Nagino M, et al. Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection. Cancer Sci. 2017;108:978\u201386.10.1111\/cas.1321928256061","DOI":"10.1111\/cas.13219"},{"key":"2025120909211363390_j_pp-2019-0003_ref_005_w2aab3b7b4b1b6b1ab1c14b5Aa","doi-asserted-by":"crossref","unstructured":"Cao F, Li J, Li A, Li F. Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis. Oncotarget. 2017;8:15004\u201313.28122342","DOI":"10.18632\/oncotarget.14745"},{"key":"2025120909211363390_j_pp-2019-0003_ref_006_w2aab3b7b4b1b6b1ab1c14b6Aa","doi-asserted-by":"crossref","unstructured":"Piso P, Arnold D. Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer. Dtsch Arztebl Int. 2011;108:802\u20138.22190994","DOI":"10.3238\/arztebl.2011.0802"},{"key":"2025120909211363390_j_pp-2019-0003_ref_007_w2aab3b7b4b1b6b1ab1c14b7Aa","doi-asserted-by":"crossref","unstructured":"Watanabe T, Hashimoto T, Sugino T, Soeda S, Nishiyama H, Morimura Y, et al. Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination. J Ovarian Res. 2012;5:7.2229675710.1186\/1757-2215-5-7","DOI":"10.1186\/1757-2215-5-7"},{"key":"2025120909211363390_j_pp-2019-0003_ref_008_w2aab3b7b4b1b6b1ab1c14b8Aa","doi-asserted-by":"crossref","unstructured":"Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, et al. Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer. Oncol Lett. 2017;15:1357\u201361.29399186","DOI":"10.3892\/ol.2017.7388"},{"key":"2025120909211363390_j_pp-2019-0003_ref_009_w2aab3b7b4b1b6b1ab1c14b9Aa","doi-asserted-by":"crossref","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364.10.2353\/ajpath.2010.10010520651229","DOI":"10.2353\/ajpath.2010.100105"},{"key":"2025120909211363390_j_pp-2019-0003_ref_010_w2aab3b7b4b1b6b1ab1c14c10Aa","doi-asserted-by":"crossref","unstructured":"Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243:137\u201347.10.1002\/path.494228722107","DOI":"10.1002\/path.4942"},{"key":"2025120909211363390_j_pp-2019-0003_ref_011_w2aab3b7b4b1b6b1ab1c14c11Aa","doi-asserted-by":"crossref","unstructured":"Flessner MF. Endothelial glycocalyx and the peritoneal barrier. Perit Dial Int. 2008;28:6\u201312.18178940","DOI":"10.1177\/089686080802800102"},{"key":"2025120909211363390_j_pp-2019-0003_ref_012_w2aab3b7b4b1b6b1ab1c14c12Aa","doi-asserted-by":"crossref","unstructured":"Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, et al. Heterotypic CAF-tumour spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019; jem.20180765.","DOI":"10.1084\/jem.2018076508222019c"},{"key":"2025120909211363390_j_pp-2019-0003_ref_013_w2aab3b7b4b1b6b1ab1c14c13Aa","doi-asserted-by":"crossref","unstructured":"Wilson R. Changes in the coelomic microclimate during carbon dioxide laparoscopy: morphological and functional implications. Pleura Peritoneum. 2017;2:17\u201331.30911629","DOI":"10.1515\/pp-2017-0001"},{"key":"2025120909211363390_j_pp-2019-0003_ref_014_w2aab3b7b4b1b6b1ab1c14c14Aa","doi-asserted-by":"crossref","unstructured":"Kitayama J, Yamaguchi H, Ishigami H, Matsuzaki K, Sata N. Intraperitoneal mesenchymal cells promote the development of peritoneal metastasis partly by supporting long migration of disseminated tumour cells. PLoS One. 2016;11:e0154542.2713692210.1371\/journal.pone.0154542","DOI":"10.1371\/journal.pone.0154542"},{"key":"2025120909211363390_j_pp-2019-0003_ref_015_w2aab3b7b4b1b6b1ab1c14c15Aa","doi-asserted-by":"crossref","unstructured":"Frisch SM, Schaller M, Cieply B. Mechanisms that link the oncogenic epithelial\u2013mesenchymal transition to suppression of anoikis. J Cell Sci. 2013;126:21\u20139.10.1242\/jcs.12090723516327","DOI":"10.1242\/jcs.120907"},{"key":"2025120909211363390_j_pp-2019-0003_ref_016_w2aab3b7b4b1b6b1ab1c14c16Aa","doi-asserted-by":"crossref","unstructured":"Cao Z, Livas T, Kyprianou N. Anoikis and EMT: lethal \u201cLiaisons\u201d during cancer progression. Crit Rev Oncog. 2016;21:155\u201368.2791596910.1615\/CritRevOncog.2016016955","DOI":"10.1615\/CritRevOncog.2016016955"},{"key":"2025120909211363390_j_pp-2019-0003_ref_017_w2aab3b7b4b1b6b1ab1c14c17Aa","doi-asserted-by":"crossref","unstructured":"Hawk MA, Schafer ZT. Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment. J Biol Chem. 2018;293:7531\u20137537.10.1074\/jbc.TM117.00026029339552","DOI":"10.1074\/jbc.TM117.000260"},{"key":"2025120909211363390_j_pp-2019-0003_ref_018_w2aab3b7b4b1b6b1ab1c14c18Aa","doi-asserted-by":"crossref","unstructured":"Cai Q, Yan L, Xu Y. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene. 2015;34:3315\u201324.10.1038\/onc.2014.26425132267","DOI":"10.1038\/onc.2014.264"},{"key":"2025120909211363390_j_pp-2019-0003_ref_019_w2aab3b7b4b1b6b1ab1c14c19Aa","doi-asserted-by":"crossref","unstructured":"Piyush T, Rhodes JM, Yu LG. MUC1 O-glycosylation contributes to anoikis resistance in epithelial cancer cells. Cell Death Discov. 2017;3:17044.2872549010.1038\/cddiscovery.2017.44","DOI":"10.1038\/cddiscovery.2017.44"},{"key":"2025120909211363390_j_pp-2019-0003_ref_020_w2aab3b7b4b1b6b1ab1c14c20Aa","doi-asserted-by":"crossref","unstructured":"Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14:632\u201341.10.1038\/nrc378925098270","DOI":"10.1038\/nrc3789"},{"key":"2025120909211363390_j_pp-2019-0003_ref_021_w2aab3b7b4b1b6b1ab1c14c21Aa","doi-asserted-by":"crossref","unstructured":"Zieseniss A. Hypoxia and the modulation of the actin cytoskeleton \u2013 emerging interrelations. Hypoxia (Auckl). 2014;2:11\u201321.27774463","DOI":"10.2147\/HP.S53575"},{"key":"2025120909211363390_j_pp-2019-0003_ref_022_w2aab3b7b4b1b6b1ab1c14c22Aa","doi-asserted-by":"crossref","unstructured":"Shen Y, Wen Z, Li Y, Matteson EL, Hong J, Goronzy JJ, et al. Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells. Nat Immunol. 2017;18:1025\u201334.10.1038\/ni.380828737753","DOI":"10.1038\/ni.3808"},{"key":"2025120909211363390_j_pp-2019-0003_ref_023_w2aab3b7b4b1b6b1ab1c14c23Aa","doi-asserted-by":"crossref","unstructured":"Satoyoshi R, Aiba N, Yanagihara K, Yashiro M, Tanaka M. Tks5 activation in mesothelial cells creates invasion front of peritoneal carcinomatosis. Oncogene. 2015;34:3176\u201387.2508819610.1038\/onc.2014.246","DOI":"10.1038\/onc.2014.246"},{"key":"2025120909211363390_j_pp-2019-0003_ref_024_w2aab3b7b4b1b6b1ab1c14c24Aa","doi-asserted-by":"crossref","unstructured":"Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, et al. Phosphorylated caveolin-1 regulates Rho\/ROCK-dependent focal adhesion dynamics and tumour cell migration and invasion. Cancer Res. 2008;68:8210\u201320.1892289210.1158\/0008-5472.CAN-08-0343","DOI":"10.1158\/0008-5472.CAN-08-0343"},{"key":"2025120909211363390_j_pp-2019-0003_ref_025_w2aab3b7b4b1b6b1ab1c14c25Aa","doi-asserted-by":"crossref","unstructured":"Ersahin T, Tuncbag N, Cetin-Atalay R. The PI3K\/AKT\/mTOR interactive pathway. Mol Biosyst. 2015;11:1946\u201354.2592400810.1039\/C5MB00101C","DOI":"10.1039\/C5MB00101C"},{"key":"2025120909211363390_j_pp-2019-0003_ref_026_w2aab3b7b4b1b6b1ab1c14c26Aa","unstructured":"Hiraga R, Kato M, Miyagawa S, Kamata T. Nox4-derived ROS signaling contributes to TGF-\u03b2-induced epithelial-mesenchymal transition in pancreatic cancer cells. Anticancer Res. 2013;33:4431\u20138.24123012"},{"key":"2025120909211363390_j_pp-2019-0003_ref_027_w2aab3b7b4b1b6b1ab1c14c27Aa","doi-asserted-by":"crossref","unstructured":"Weber GF. Metabolism in cancer metastasis. Int J Cancer. 2016;138:2061\u20136.2635549810.1002\/ijc.29839","DOI":"10.1002\/ijc.29839"},{"key":"2025120909211363390_j_pp-2019-0003_ref_028_w2aab3b7b4b1b6b1ab1c14c28Aa","doi-asserted-by":"crossref","unstructured":"Du S, Miao J, Zhu Z, Xu E, Shi L, Ai S, et al. NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. Cell Death Dis. 2018;9:948.3023742310.1038\/s41419-018-0953-7","DOI":"10.1038\/s41419-018-0953-7"},{"key":"2025120909211363390_j_pp-2019-0003_ref_029_w2aab3b7b4b1b6b1ab1c14c29Aa","doi-asserted-by":"crossref","unstructured":"Hanson RL, Hollingsworth MA. Functional consequences of differential O-glycosylation of MUC1, MUC4, and MUC16 (downstream effects on signaling). Biomolecules. 2016;6:34.","DOI":"10.3390\/biom6030034"},{"key":"2025120909211363390_j_pp-2019-0003_ref_030_w2aab3b7b4b1b6b1ab1c14c30Aa","doi-asserted-by":"crossref","unstructured":"Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med. 2014;20:332\u201342.2466713910.1016\/j.molmed.2014.02.007","DOI":"10.1016\/j.molmed.2014.02.007"},{"key":"2025120909211363390_j_pp-2019-0003_ref_031_w2aab3b7b4b1b6b1ab1c14c31Aa","doi-asserted-by":"crossref","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumours in the body, J. Gen Physiol. 1927;8:519\u201330.10.1085\/jgp.8.6.519","DOI":"10.1085\/jgp.8.6.519"},{"key":"2025120909211363390_j_pp-2019-0003_ref_032_w2aab3b7b4b1b6b1ab1c14c32Aa","doi-asserted-by":"crossref","unstructured":"Wilson RB. Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis. Pleura Peritoneum. 2018:3.30911653","DOI":"10.1515\/pp-2018-0103"},{"key":"2025120909211363390_j_pp-2019-0003_ref_033_w2aab3b7b4b1b6b1ab1c14c33Aa","unstructured":"Stambrovskaia AA. Diagnostic value of determination of the content of glucose, aldolase and lactic acid in the blood serum and exudate from the abdominal cavity in ovarian neoplasms. Akush Ginekol (Mosk). 1974;10:23\u20135."},{"key":"2025120909211363390_j_pp-2019-0003_ref_034_w2aab3b7b4b1b6b1ab1c14c34Aa","doi-asserted-by":"crossref","unstructured":"Yu L, Chen X, Sun X, Wang L, Chen S. The glycolytic switch in tumours: how many players are involved? J Cancer. 2017;8:3430\u201340.10.7150\/jca.2112529151926","DOI":"10.7150\/jca.21125"},{"key":"2025120909211363390_j_pp-2019-0003_ref_035_w2aab3b7b4b1b6b1ab1c14c35Aa","unstructured":"Rempel A, Mathupala SP, Griffin CA, Hawkins AL, Pedersen PL. Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res. 1996;56:2468\u201371.8653677"},{"key":"2025120909211363390_j_pp-2019-0003_ref_036_w2aab3b7b4b1b6b1ab1c14c36Aa","doi-asserted-by":"crossref","unstructured":"Dang CV, Kim JW, Gao P, Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8:51\u20136.1804633410.1038\/nrc2274","DOI":"10.1038\/nrc2274"},{"key":"2025120909211363390_j_pp-2019-0003_ref_037_w2aab3b7b4b1b6b1ab1c14c37Aa","doi-asserted-by":"crossref","unstructured":"Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8:705\u201313.10.1038\/nrc246819143055","DOI":"10.1038\/nrc2468"},{"key":"2025120909211363390_j_pp-2019-0003_ref_038_w2aab3b7b4b1b6b1ab1c14c38Aa","doi-asserted-by":"crossref","unstructured":"Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, et al. Inactivation of the HIF-1alpha\/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res. 2012;72:5035\u201347.10.1158\/0008-5472.CAN-12-097922865452","DOI":"10.1158\/0008-5472.CAN-12-0979"},{"key":"2025120909211363390_j_pp-2019-0003_ref_039_w2aab3b7b4b1b6b1ab1c14c39Aa","doi-asserted-by":"crossref","unstructured":"Huang D, Li C, Zhang H. Hypoxia and cancer cell metabolism. Acta Biochim Biophys Sin (Shanghai). 2014;46:214\u20139.2438964210.1093\/abbs\/gmt148","DOI":"10.1093\/abbs\/gmt148"},{"key":"2025120909211363390_j_pp-2019-0003_ref_040_w2aab3b7b4b1b6b1ab1c14c40Aa","unstructured":"Icard P, Fournel L, Wu Z, Alifano M, Lincet H. Interconnection between metabolism and cell cycle in cancer. Trends Biochem Sci. 2019 pii: S0968-0004(18)30273-1.30655165"},{"key":"2025120909211363390_j_pp-2019-0003_ref_041_w2aab3b7b4b1b6b1ab1c14c41Aa","doi-asserted-by":"crossref","unstructured":"Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J, et al. Metabolic coupling and the Reverse Warburg Effect in cancer: implications for novel biomarker and anticancer agent development. Semin Oncol. 2017;44:198\u2013203.2924813110.1053\/j.seminoncol.2017.10.004","DOI":"10.1053\/j.seminoncol.2017.10.004"},{"key":"2025120909211363390_j_pp-2019-0003_ref_042_w2aab3b7b4b1b6b1ab1c14c42Aa","doi-asserted-by":"crossref","unstructured":"Dunlop EA, Tee AR. mTOR and autophagy: a dynamic relationship governed by nutrients and energy. Semin Cell Dev Biol. 2014;36:121\u20139.10.1016\/j.semcdb.2014.08.00625158238","DOI":"10.1016\/j.semcdb.2014.08.006"},{"key":"2025120909211363390_j_pp-2019-0003_ref_043_w2aab3b7b4b1b6b1ab1c14c43Aa","doi-asserted-by":"crossref","unstructured":"Cho ES, Cha YH, Kim HS, Kim NH, Yook JI. The pentose phosphate pathway as a potential target for cancer therapy. Biomol Ther (Seoul). 2018;26:29\u201338.10.4062\/biomolther.2017.17929212304","DOI":"10.4062\/biomolther.2017.179"},{"key":"2025120909211363390_j_pp-2019-0003_ref_044_w2aab3b7b4b1b6b1ab1c14c44Aa","doi-asserted-by":"crossref","unstructured":"Hu Y, Lu W, Chen G, Wang P, Chen Z, Zhou Y, et al. K- ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res. 2012;22:399\u2013412.10.1038\/cr.2011.145","DOI":"10.1038\/cr.2011.145"},{"key":"2025120909211363390_j_pp-2019-0003_ref_045_w2aab3b7b4b1b6b1ab1c14c45Aa","doi-asserted-by":"crossref","unstructured":"Duan L, Perez RE, Davaadelger B, Dedkova EN, Blatter LA, Maki CG. p53-regulated autophagy is controlled by glycolysis and determines cell fate. Oncotarget. 2015;6:23135\u201356.26337205","DOI":"10.18632\/oncotarget.5218"},{"key":"2025120909211363390_j_pp-2019-0003_ref_046_w2aab3b7b4b1b6b1ab1c14c46Aa","doi-asserted-by":"crossref","unstructured":"Alfarouk KO, Verduzco D, Rauch C, Muddathir AK, Adil HH, Elhassan GO, et al. Glycolysis, tumour metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience. 2014;1:777\u2013802.10.18632\/oncoscience.109","DOI":"10.18632\/oncoscience.109"},{"key":"2025120909211363390_j_pp-2019-0003_ref_047_w2aab3b7b4b1b6b1ab1c14c47Aa","doi-asserted-by":"crossref","unstructured":"Granchi C, Minutolo F. Anticancer agents that counteract tumour glycolysis. Chem Med Chem. 2012;7:1318\u201350.10.1002\/cmdc.201200176","DOI":"10.1002\/cmdc.201200176"},{"key":"2025120909211363390_j_pp-2019-0003_ref_048_w2aab3b7b4b1b6b1ab1c14c48Aa","doi-asserted-by":"crossref","unstructured":"Huang R, Zong X. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: mechanisms in cancer progression. Crit Rev Oncol Hematol. 2017;115:13\u201322.2860216510.1016\/j.critrevonc.2017.04.005","DOI":"10.1016\/j.critrevonc.2017.04.005"},{"key":"2025120909211363390_j_pp-2019-0003_ref_049_w2aab3b7b4b1b6b1ab1c14c49Aa","doi-asserted-by":"crossref","unstructured":"Valvona CJ, Fillmore HL, Nunn PB, Pilkington GJ. The regulation and function of Lactate Dehydrogenase A: therapeutic potential in brain tumour. Brain Pathol. 2016;26:3\u201317.2626912810.1111\/bpa.12299","DOI":"10.1111\/bpa.12299"},{"key":"2025120909211363390_j_pp-2019-0003_ref_050_w2aab3b7b4b1b6b1ab1c14c50Aa","doi-asserted-by":"crossref","unstructured":"Satoyoshi R, Kuriyama S, Aiba N, Yashiro M, Tanaka M. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts. Oncogene. 2015;34:650\u201360.2444103910.1038\/onc.2013.584","DOI":"10.1038\/onc.2013.584"},{"key":"2025120909211363390_j_pp-2019-0003_ref_051_w2aab3b7b4b1b6b1ab1c14c51Aa","doi-asserted-by":"crossref","unstructured":"Thuwajit C, Ferraresi A, Titone R, Thuwajit P, Isidoro C. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: autophagy plays a role. Med Res Rev. 2017;38:1235\u201354.","DOI":"10.1002\/med.21473"},{"key":"2025120909211363390_j_pp-2019-0003_ref_052_w2aab3b7b4b1b6b1ab1c14c52Aa","doi-asserted-by":"crossref","unstructured":"Avagliano A, Granato G, Ruocco MR, Romano V, Belviso I, Carfora A, et al. Metabolic reprogramming of Cancer Associated Fibroblasts: the slavery of stromal fibroblasts. Biomed Res Int. vol. 2018, Article ID 6075403, 12 pages, 2018.","DOI":"10.1155\/2018\/6075403"},{"key":"2025120909211363390_j_pp-2019-0003_ref_053_w2aab3b7b4b1b6b1ab1c14c53Aa","doi-asserted-by":"crossref","unstructured":"Shangguan C, Gan G, Zhang J, Wu J, Miao Y, Zhang M, et al. Cancer-associated fibroblasts enhance tumour 18F-FDG uptake and contribute to the intratumour heterogeneity of PET-CT. Theranostics. 2018;8:1376\u201388.10.7150\/thno.22717","DOI":"10.7150\/thno.22717"},{"key":"2025120909211363390_j_pp-2019-0003_ref_054_w2aab3b7b4b1b6b1ab1c14c54Aa","doi-asserted-by":"crossref","unstructured":"Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, et al. Warburg meets autophagy: cancer-Associated Fibroblasts accelerate tumour growth and metastasis via oxidative Stress, mitophagy, and aerobic glycolysis. Antiox Redox Signal. 2012;16:1264\u201384.10.1089\/ars.2011.4243","DOI":"10.1089\/ars.2011.4243"},{"key":"2025120909211363390_j_pp-2019-0003_ref_055_w2aab3b7b4b1b6b1ab1c14c55Aa","doi-asserted-by":"crossref","unstructured":"Romero IL, Mukherjee A, Kenny HA, Litchfield LM, Lengyel E. Molecular pathways: trafficking of metabolic resources in the tumour microenvironment. Clin Cancer Res. 2015;21:680\u20136.10.1158\/1078-0432.CCR-14-219825691772","DOI":"10.1158\/1078-0432.CCR-14-2198"},{"key":"2025120909211363390_j_pp-2019-0003_ref_056_w2aab3b7b4b1b6b1ab1c14c56Aa","doi-asserted-by":"crossref","unstructured":"Yang L, Achreja A, Yeung TL, Mangala LS, Jiang D, Han C, et al. Targeting stromal glutamine synthetase in tumours disrupts tumour microenvironment-regulated cancer cell growth. Cell Metab. 2016;24:685\u2013700.2782913810.1016\/j.cmet.2016.10.011","DOI":"10.1016\/j.cmet.2016.10.011"},{"key":"2025120909211363390_j_pp-2019-0003_ref_057_w2aab3b7b4b1b6b1ab1c14c57Aa","doi-asserted-by":"crossref","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumour growth. Nat Med. 2011;17:1498\u2013503.10.1038\/nm.249222037646","DOI":"10.1038\/nm.2492"},{"key":"2025120909211363390_j_pp-2019-0003_ref_058_w2aab3b7b4b1b6b1ab1c14c58Aa","doi-asserted-by":"crossref","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5:e189.10.1038\/oncsis.2015.4926807644","DOI":"10.1038\/oncsis.2015.49"},{"key":"2025120909211363390_j_pp-2019-0003_ref_059_w2aab3b7b4b1b6b1ab1c14c59Aa","doi-asserted-by":"crossref","unstructured":"Lincet H, Icard P. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? Oncogene. 2014;34:3751\u20139.25263450","DOI":"10.1038\/onc.2014.320"},{"key":"2025120909211363390_j_pp-2019-0003_ref_060_w2aab3b7b4b1b6b1ab1c14c60Aa","doi-asserted-by":"crossref","unstructured":"Yu X, Li S. Non-metabolic functions of glycolytic enzymes in tumourigenesis. Oncogene. 2017;6:2629\u201336.","DOI":"10.1038\/onc.2016.410"},{"key":"2025120909211363390_j_pp-2019-0003_ref_061_w2aab3b7b4b1b6b1ab1c14c61Aa","doi-asserted-by":"crossref","unstructured":"Nordhausen K, Solass W, Demtr\u00f6der C, Tempfer CB, Reymond MA. Cachexia-anorexia syndrome in patients with peritoneal metastasis: an observational study. Pleura Peritoneum. 2016;1:57\u201363.30911608","DOI":"10.1515\/pp-2016-0003"},{"key":"2025120909211363390_j_pp-2019-0003_ref_062_w2aab3b7b4b1b6b1ab1c14c62Aa","doi-asserted-by":"crossref","unstructured":"Chen JL, Walton KL, Hagg A, Colgan TD, Johnson K, Qian H, et al. Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease. Proc Natl Acad Sci USA. 2017;114:E5266\u201375.","DOI":"10.1073\/pnas.1620013114"},{"key":"2025120909211363390_j_pp-2019-0003_ref_063_w2aab3b7b4b1b6b1ab1c14c63Aa","doi-asserted-by":"crossref","unstructured":"Trendelenburg AU, Meyer A, Jacobi C, Feige JN, Glass DJ. TAK-1\/p38\/nNF\u03baB signaling inhibits myoblast differentiation by increasing levels of Activin A. Skelet Muscle. 2012;2:3.2231386110.1186\/2044-5040-2-3","DOI":"10.1186\/2044-5040-2-3"},{"key":"2025120909211363390_j_pp-2019-0003_ref_064_w2aab3b7b4b1b6b1ab1c14c64Aa","doi-asserted-by":"crossref","unstructured":"Seki SM, Gaulier A. Exploring non-Metabolic Functions of Glycolytic enzymes in immunity. Front Immunol. 2017;8:1549.10.3389\/fimmu.2017.0154929213268","DOI":"10.3389\/fimmu.2017.01549"},{"key":"2025120909211363390_j_pp-2019-0003_ref_065_w2aab3b7b4b1b6b1ab1c14c65Aa","doi-asserted-by":"crossref","unstructured":"Dvorak HF. Tumors: wounds that do not heal-redux. Cancer Immunol Res. 2015;3:1\u201311.10.1158\/2326-6066.CIR-14-020925568067","DOI":"10.1158\/2326-6066.CIR-14-0209"},{"key":"2025120909211363390_j_pp-2019-0003_ref_066_w2aab3b7b4b1b6b1ab1c14c66Aa","unstructured":"Lu S, Wang Y. Nonmetabolic functions of metabolic enzymes in cancer development. Cancer Commun (Lond). 2018;38:63.3036767610.1186\/s40880-018-0336-6"},{"key":"2025120909211363390_j_pp-2019-0003_ref_067_w2aab3b7b4b1b6b1ab1c14c67Aa","doi-asserted-by":"crossref","unstructured":"Wegiel B, Vuerich M, Daneshmandi S, Seth P. Metabolic switch in the tumour microenvironment determines immune responses to anti-cancer therapy. Front Oncol. 2018;8:284.10.3389\/fonc.2018.0028430151352","DOI":"10.3389\/fonc.2018.00284"},{"key":"2025120909211363390_j_pp-2019-0003_ref_068_w2aab3b7b4b1b6b1ab1c14c68Aa","doi-asserted-by":"crossref","unstructured":"Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst. 2004;96:1702\u201313.1554718310.1093\/jnci\/djh305","DOI":"10.1093\/jnci\/djh305"},{"key":"2025120909211363390_j_pp-2019-0003_ref_069_w2aab3b7b4b1b6b1ab1c14c69Aa","doi-asserted-by":"crossref","unstructured":"Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 2012;72:2746\u201356.10.1158\/0008-5472.CAN-11-127222593198","DOI":"10.1158\/0008-5472.CAN-11-1272"},{"key":"2025120909211363390_j_pp-2019-0003_ref_070_w2aab3b7b4b1b6b1ab1c14c70Aa","doi-asserted-by":"crossref","unstructured":"Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, Russell S, Weber AM, Luddy K, et al. Neutralization of tumor acidity improves antitumor responses to immunotherapy. Cancer Res. 2016;76:1381\u201390.10.1158\/0008-5472.CAN-15-174326719539","DOI":"10.1158\/0008-5472.CAN-15-1743"},{"key":"2025120909211363390_j_pp-2019-0003_ref_071_w2aab3b7b4b1b6b1ab1c14c71Aa","doi-asserted-by":"crossref","unstructured":"Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong SW, et al. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K\/AKT pathway. J Hematol Oncol. 2015;8:22.10.1186\/s13045-015-0117-525887760","DOI":"10.1186\/s13045-015-0117-5"},{"key":"2025120909211363390_j_pp-2019-0003_ref_072_w2aab3b7b4b1b6b1ab1c14c72Aa","doi-asserted-by":"crossref","unstructured":"Li X, Qian X, Jiang H, Xia Y, Zheng Y, Li J, et al. Nuclear PGK1 alleviates ADP-dependent inhibition of CDC7 to promote DNA replication. Mol Cell. 2018;72:650\u201360.10.1016\/j.molcel.2018.09.00730392930","DOI":"10.1016\/j.molcel.2018.09.007"},{"key":"2025120909211363390_j_pp-2019-0003_ref_073_w2aab3b7b4b1b6b1ab1c14c73Aa","doi-asserted-by":"crossref","unstructured":"Israelsen WJ, Vander Heiden MG. Pyruvate kinase: function, regulation and role in cancer. Sem Cell Dev Biol. 2015;43:43\u201351.10.1016\/j.semcdb.2015.08.004","DOI":"10.1016\/j.semcdb.2015.08.004"},{"key":"2025120909211363390_j_pp-2019-0003_ref_074_w2aab3b7b4b1b6b1ab1c14c74Aa","doi-asserted-by":"crossref","unstructured":"Sun S, Liang X, Zhang X, Liu T, Shi Q, Song Y, et al. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer. Br J Cancer. 2015;112:1332\u20139.10.1038\/bjc.2015.114","DOI":"10.1038\/bjc.2015.114"},{"key":"2025120909211363390_j_pp-2019-0003_ref_075_w2aab3b7b4b1b6b1ab1c14c75Aa","doi-asserted-by":"crossref","unstructured":"Hu H, Zhu W, Qin J, Chen M, Gong L, Li L, et al. Acetylation of PGK1 promotes liver cancer cell proliferation and tumourigenesis. Hepatology. 2017;65:515\u201328.10.1002\/hep.28887","DOI":"10.1002\/hep.28887"},{"key":"2025120909211363390_j_pp-2019-0003_ref_076_w2aab3b7b4b1b6b1ab1c14c76Aa","doi-asserted-by":"crossref","unstructured":"Ahmad SS, Glatzle J, Bajaeifer K, B\u00fchler S, Lehmann T, K\u00f6nigsrainer I, et al. Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer. Int J Oncol. 2013;43:586\u201390.10.3892\/ijo.2013.197123727790","DOI":"10.3892\/ijo.2013.1971"},{"key":"2025120909211363390_j_pp-2019-0003_ref_077_w2aab3b7b4b1b6b1ab1c14c77Aa","doi-asserted-by":"crossref","unstructured":"Zieker D, K\u00f6nigsrainer I, Traub F, Nieselt K, Knapp B, Schillinger C, et al. PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem. 2008;21:429\u201336.10.1159\/00012963518453750","DOI":"10.1159\/000129635"},{"key":"2025120909211363390_j_pp-2019-0003_ref_078_w2aab3b7b4b1b6b1ab1c14c78Aa","doi-asserted-by":"crossref","unstructured":"Li X, Jiang Y, Meisenhelder J, Yang W, Hawke DH, Zheng Y, et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumourigenesis. Mol Cell. 2016;61:705\u201319.10.1016\/j.molcel.2016.02.009","DOI":"10.1016\/j.molcel.2016.02.009"},{"key":"2025120909211363390_j_pp-2019-0003_ref_079_w2aab3b7b4b1b6b1ab1c14c79Aa","doi-asserted-by":"crossref","unstructured":"Zieker D, K\u00f6nigsrainer I, Tritschler I, L\u00f6ffler M, Beckert S, Traub F, et al. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer. 2010;126:1513\u201320.19688824","DOI":"10.1002\/ijc.24835"},{"key":"2025120909211363390_j_pp-2019-0003_ref_080_w2aab3b7b4b1b6b1ab1c14c80Aa","doi-asserted-by":"crossref","unstructured":"Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, et al. Role of the CXCL12\/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 2006;66:2181\u20137.10.1158\/0008-5472.CAN-05-339316489019","DOI":"10.1158\/0008-5472.CAN-05-3393"},{"key":"2025120909211363390_j_pp-2019-0003_ref_081_w2aab3b7b4b1b6b1ab1c14c81Aa","doi-asserted-by":"crossref","unstructured":"Zieker D, K\u00f6nigsrainer I, Weinreich J, Beckert S, Glatzle J, Nieselt K, et al. Phosphoglycerate kinase 1 promoting tumour progression and metastasis in gastric cancer \u2013 detected in a tumour mouse model using positron emission tomography\/magnetic resonance imaging. Cell Physiol Biochem. 2010;26:147\u201354.10.1159\/000320545","DOI":"10.1159\/000320545"},{"key":"2025120909211363390_j_pp-2019-0003_ref_082_w2aab3b7b4b1b6b1ab1c14c82Aa","doi-asserted-by":"crossref","unstructured":"Katoh M, Katoh M. Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors. Int J Oncol. 2010;36:415\u201320.20043076","DOI":"10.3892\/ijo_00000514"},{"key":"2025120909211363390_j_pp-2019-0003_ref_083_w2aab3b7b4b1b6b1ab1c14c83Aa","doi-asserted-by":"crossref","unstructured":"Minnaert AK, Dakwar GR, Benito JM, Garc\u00eda Fern\u00e1ndez JM, Ceelen W, De Smedt SC, et al. High-pressure nebulization as application route for the peritoneal administration of siRNA complexes. Macromol Biosci. 2017:17. DOI:10.1002\/mabi.201700024.","DOI":"10.1002\/mabi.201700024"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/4\/1\/article-20190003.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2019-0003\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2019-0003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:46:29Z","timestamp":1765277189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2019-0003\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,26]]},"published-print":{"date-parts":[[2019,3,26]]}},"alternative-id":["10.1515\/pp-2019-0003"],"URL":"https:\/\/doi.org\/10.1515\/pp-2019-0003","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"value":"2364-768X","type":"electronic"},{"value":"2364-7671","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"article-number":"20190003"}}